About The Journal
  Aims and Scope
  Editorial Board
  Submit a Manuscript 
  Subscription Information
  Guidelines for Publication
  Ethics
Articles & Issues
  Search
  Issue
  Online First
  KJChE on
For Authors
  Instructions to Authors
  Ethical Responsibilities of
  Authors in KJChE
  Ethics in Publishing
  Peer Review Process
  Author's Checklist
  Copyright Transfer Form
Contact us
 
 
 
Issue
Korean Journal of Chemical Engineering,
Vol.27, No.4, 1139-1144, 2010
Micronization and characterization of drug substances by RESS with supercritical CO2
Kim JT, Kim HL, Ju CS
A RESS (rapid expansion of supercritical solution) process for the preparation of ultra-fine drug particles with no organic solvent has been developed with supercritical CO2. Three drug substances with different solubility in supercritical CO2 were used, and orifice disks and capillary tubes were adapted as an expansion device. The solubilities of drug substances in supercritical CO2 and the effects of various operating parameters on the characteristics of the particles prepared by RESS process were experimentally investigated. The solubility of the drug substance in supercritical CO2 had a major effect on the average diameter of the particle prepared by RESS process, and the particle diameter decreased with the solubility for all the drugs and operating conditions. The particle diameter also decreased with preexpansion temperature and increased with the hole diameter of the orifice nozzle and aspect ratio (L/D) of the capillary tube.
Keywords: RESS; Drug Substances; Micronization; Solubility; Supercritical
[References]
  1. Sun YP, Supercritical fluid technology in materials science and engineering, Marcel Dekker, Inc., New York, 2002
  2. Gupta RB, Shim JJ, Solubility in supercritical carbon dioxide., CRC Press, New York, 2007
  3. Paulaitis ME, Krukonis VJ, Kurnik RT, Reid RC, Rev.Chem. Eng., 1(2), 179, 1983
  4. Tavana A, Randolph AD, AIChE J., 35(10), 1625, 1989
  5. Thakur R, Gupta RB, Internat’l. J. Pharm., 308, 190, 2006
  6. Charpentier PA, Jia M, Lucky RA, AAPS Pharm. Sci. Tech., 9, 39, 2008
  7. Liu YQ, Zhang FX, Sun YY, Zhao G, JCT Research., 5, 465, 2008
  8. Helfgen B, Turk M, Schaber K, Powder Technol., 110(1-2), 22, 2000
  9. Sun YP, Guduru R, Lin F, Whiteside T, Ind. Eng. Chem. Res., 39(12), 4663, 2000
  10. Santo IR, Richard J, Pech B, Thies C, Benoit JP, Int. J.Pharm., 242, 69, 2002
  11. Mishima K, Matsuyama K, Tanabe D, Yamauchi S, Young TJ, Johnston KP, AIChE J., 46(4), 857, 2000
  12. Glebov EM, Yuan L, Krishtopa LG, Usov OM, Krasnoperov LN, Ind. Eng. Chem. Res., 40(19), 4058, 2001
  13. Frank SG, Ye C, Proc. 5th Int’al Symp. on SF, April, Atlanta
  14. Jara-Morante E, Suleiman D, Estevez LA, Ind. Eng. Chem. Res., 42(8), 1821, 2003
  15. Vandana V, Teja AS, Fluid Phase Equilib., 135(1), 83, 1997
  16. Ju CS, Cheon JK, Lee SH, Hong SS, Kim HL, Woo KJ, J. Korean Ind. Eng. Chem., 13(1), 69, 2002
  17. Kim BM, Lee SH, Cheon JK, Lee MG, Ju CS, Korean Chem. Eng. Res., 38, 387, 2000
  18. Kim JH, Paxton TE, Tomasko DL, Biotechnol. Prog., 12(5), 650, 1996
참고문헌정보(참고문헌, 인용문헌)는 화학공학소재연구정보센터에 의해 제공되고 있습니다.